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CORRELATION OF TISSUE·TYPING TESTS IN BABOON RENAL ALLOTRANSPLANTS*
A PRELIMI 'ARY ST DY
G. P. MURPHY, lames Buchanan Brady Urological Institute, lohns Hopkins Hospital, Baltimore, Maryland, USA;
H. D. BREDE, H. W. WEBER, F. P. RETIEF, J. J. W. VAN ZYL, J. A. VA ZYL A ID J. . DE KLERK, FaCIlIty of
Medicine, University of Stellenbosch and Karl Bremer Hospital, Bellville, CP
This report deals with the frequency of occurrence of
various human leucocyte antigens and their relative in-
fluence on the survival period of baboons subjected to
renal allotransplantation, both with and without simul-
taneous immunosuppressive treatment. In all the experi-
ments the compatibility of the donor and recipient pairs
were matched in terms of their human (ABO) blood-group
antigens.
In the absence of a safe method of inducing immuno-
logical tolerance to renal-graft antigens in man, it seems
inevitable that non-specific immunosuppression will con-
tinue to be necessary in the management of graft reci-
pients for the foreseeable future. The need for immuno-
suppression, with its attendant hazards, may be reduced if
it becomes possible to select a donor compatible with the
recipient in respect of the strongest antigens. Human leuco-
cyte typing is at present advocated as a valuable method
of tissue typing to obtain better graft matching.'" Reports
from large groups of human patients receiving renal homo-
transplants from pre-operatively matched donors are,
however, not yet available.
The experiments reported here afford an opportunity to
determine the relative significance of various human-type
'Report No. 15 from the Stellenbosch·Johns Hopkins Primate Project.
leucocyte antigens in immunologically competent sub-
human primates, receiving renal allografts.
MATERIALS AND METHODS
Renal allografts were performed on 34 adult male and
female Chacma baboons (Papio papio, sub-species Papio
ursinus). In 5 pairs of donors and recipients, grafts were
exchanged without loss or sacrifice of the donor. A total
of 22 pairs of renal allotransplants were thus performed
(Table I).
The animals were housed and cared for in the Stellen-
bosch-Johns Hopkins Primate Project at the Karl Bremer
Hospital in BeUville, CP. The details of the operative
technique and various chemical tests have recently been
described in detail.' As human blood substances are not
found on the baboon erythrocytes: the human ABO
blood-groups were determined by two indirect methods.
Saliva specimens were examined for the ability to inhibit
the activity of human erythrocyte-typing antisera and
serum specimens were examined for agglutinins to human
erythrocytes. The animals were from heterogeneous troops
trapped in widely scattered locations in the Cape Western
Province and the grafts were performed between animals
from different troops. The unknown effects of inbreeding
and natural biological selection, more likely present within
TABLE I. LEUCOCYTI! TYPING RESULTS
Day Human Number Specific groups Number Specific groups
PO ABO differences· differences· differences· differences·
No. Treatment Donor Recipient death groups D--'>-R D--'>-R R--'>-D R--'>-D
I Control V-20 P-20 l7 AB--'>-AB 10 1,5,7,9, 11, 17, 18,20, None None
2 Control
21,22
P-20 V-20 6 AB--'>-AB 0 None 10 1,5,7,9, 11, 18,20,21,
3 Control W 12 W-I4
22, l7
15 B--'>-B 4 3,6, 10, 12 None None
4 Control W14 W-I2 11 B--'>-B 0 None 4 3,6, 10, 12
5 Thalidomide A 20 A-I9 12 B--'>-B 1 2 11 1,4,5,6,7,8,9,10,11,
6 Thalidomide C-l7
15,18
C-18 6 B--'>-B 1 1 5 5,7,8, 16,21
7 Chloroquine Y-6 Y-7 15 B--'>-B 1 12 4 3, 13, 18,20
8 Chloroquine Z-9 A-II 5 B--'>-B 8 1,2, 3, 10, 14,20,21,22 6 4,11,15,16,17,18
9 Chloroquine Z-3 Y-9 8 B--'>-B 5 4,17,18,21,22 7 3,9, 10, 12, 14, 19,20
10 Imuran B-21 A-27 7 B--'>-B 0 None 2 3, 20
11 RNA-ase R-12 Q-20 9 AB--'>-AB 0 None 3 6, 17, 19
12 RNA-ase T-20 U-Il 6 B--'>-B 0 Tone 14 1,5,8,11,14,15,17,19,
13 RNA-ase Q-18 R-I4
20, 21, 22, 23, 24, 26
4 B--'>-B 0 None 8 1,2,12,13,15,19,20,22
14 Goat y-globulin 1-20 K-18 11 B--'>-B 14 2,4,5,6,7,8,9,10,14,16, I 22
15 Kidney-ce11 fractions W-16
17, 18,25,26
L-II 7 B--'>-B 0 None 0 None
16 Kidney-cell fractions T-18 T-I7 6 B--'>-B 3 6,12,22 3 3,4,24
17 Kidney-cell fractions T-17 T-I8 6 B--'>-B 3 3,4.24 3 6,12,22
18 Kidney-cell fractions T-I4 T-13 7 AB--'>-AB 3 8, 18,25 0 one
19 Kidney-cell fractions T-13 T-I4 8 AB--'>-AB 0 one 3 8,18,25
20 Kidney-cell fractions R-13 R-II 5 B--'>-B I 17 4 6,13,14,26
21 Cortisone A-27 B-21 5 B--'>-B 2 3,20 0 one
22 Cortisone . A-28 Y-15 7 A--'>-A 2 7,16 7 2,4, 5, 6, 12,21,23
D=donor
R = recipier·t
-For - or greater agglutinin reactions.
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a single troop, were therefore avoided. As a result of
avoiding the possibility of blood relationship between the
donor and recipient, the survival periods may have been
shorter than those noted after transplantation between
members of the isolated, inbred troop of animals in the
Cape Point Reserve:
At the time of surgery 10 ml. of EDTA blood were
obtained from the donor and recipient. Baboon leucocytes
were then tested against a battery of 26 human leucocyte
antisera at the Cape Provincial Blood Grouping Labora-
tory.* This method of leucoagglutination as a test for tissue
typing antigens has been described in detail:'- The human
antisera were originally obtained from a panel of pregnant
women..·• Agglutination reactions of baboon leucocytes in
the specific antisera were recorded as W + (weakly-posi-
tive), +, + + and + + +. Occasional stromal reactions
were noted.
In the 22 paired baboon renal allografts, 4 were not
subjected to immunosuppressive therapy, while the remain-
ing 18 pairs were subjected to various forms of therapy.
The following substances were administered by parenteral
injection at operation and postoperatively, at varying inter-
vals: Thalidomide (l0 mg./kg.), chloroquine (5 mg./kg.),
Imuran (3 mg./kg.), R A-ase (300 mg.), anti-baboon goat
y-globulin (600 mg.), subcellular baboon kidney-cell frac-
tions (2 ml.) and cortisone (60 mg.). The results of these
forms of treatment and various other tests will be
described in detail in a separate communication. Animals
in the present series underwent renal rejection as deter-
mined by their clinical course, chemical tests, or gross and
histopathologic postmortem examinations. None of the
animals survived beyond 3 weeks and they are therefore
comparable in terms of their response to renal allotrans-
plantation, despite the differing modes of therapy.
The same battery of specific human leucocyte antisera
were used in leucocyte agglutination tests on 100 other
baboons. In addition, leucocyte matching tests were per-
formed between human renal homotransplant candidates
and baboons with similar human blood-groups. In one
instance a modified third-man skin test was employed
using two baboons of the same blood-group as the patient.'
An autograft of skin was applied as a control and split-
thickness skin grafts from the other baboon and the poten-
tial human recipient were transplanted. Other specific tests
performed in special instances will be described in the
text. Details of the various methods can be found else-
where.'
Furthermore, in a series of experiments on organ preser-
vation, 20 baboon kidneys were subjected to bloodless
perfusion for 24 hours under hypothermic, hyperbaric con-
ditions in a specially designed unit, using either helium or
oxygen as the equilibrating gas.' The perfusate, a dextrose
and water solution to which other substances were added,
recirculates through the kidneys during the preservation.
The fluid caused no reaction with the battery of 26 human
antisera before or after the 24-hour preservation period.
In a further experiment a blood- and leucocyte-typed
baboon was killed and various organs were then removed
and washed out to remove all blood cells, and were then
freeze-dried. Homogenates of these tissues were tested for
*The serological tests involved were carried out in the Provincial Blood
Grouping Laboratory under the direction of Dr M.C. Botha.
reactions against the same set of 26 human antisera:"
The principles and practices of the South African Ani-
mal Welfare Society and the American National Society
for Medical Research were observed throughout these
experiments.
RESULTS
Frequency Distribution. of Leucocyte Agglutination Re-
actions Against Specific Antisera
Figs. 1 and 2 indicate the relative frequency of aggluti-
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Fig. 1. The relative frequency of weakly-positive baboon
leucocyte agglutination reactions to the battery of 26
human antisera.
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Fig. 2. The relative frequency of strongly-positive baboon
leucocyte agglutination reactions to the battery of 26
human antisera
screening test against each of the 26 human antisera. Fig. 1
illustrates the relative frequency of weak-positive reactions
(W +), while Fig. 2 illustrates the relative frequency of
stronger (+ +) agglutination reactions.
Fig. 1 shows that 3 main peaks of incidence are seen,
indicating that the most frequently occurring leucocyte
antigens are those reacting against the human antisera
numbered 4, 13 and 19. It-is not yet known how these 3
main groups may differ from one another antigenically, but
it is possible that they may be sirnilar.3.' The scale of
reactivity was set at the lowest level (weak-positive) which
may result in lower specificity than stronger reactions.
However, as shown in Fig. 2, the strongest leucocyte re-
actions are also distributed into 4 groups, against antisera
3, 13, 16 and 21. Allowing for biological overlapping, this
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is quite close to the groups most frequently found with
those baboon leucocytes giving a weak-positive reaction
(Fig. 1). The system of numerical identification of the
human antisera used in the present study will be retained
for future use, but it is unknown at present in what way
these 26 numbered antisera are similar to or different from
the antisera employed by other investigators.
In all the animals tested there were 1,197 negative re-
actions, 343 W + reactions, 304 + reactions, 70 ++
reactions and one + + + reaction. These numbers thus
constitute an extensive biological sample of the various
types of leucocytes seen in 100 ba boons as tested by our
battery of 26 human antisera.
Donor and Recipient Leucocyte Typing Differences
Data on the survival after renal allotransplantation of
the 22 pairs of grafted animals are shown in Table I. The
correlation between donor and recipient leucocyte agglu-
tination reactions with the antisera will be discussed
separately.
Differences in survival of treated and untreated renal
allotransplanted baboons were related to the observed
discrepancies in leucocyte typing results. In the presence
in the donor of more than 5 antigens not present in the
recipient, only 2 of 22 (or 9·1 %) of the recipients survived
beyond 10 days, with or without antirejection therapy.
In the presence in the recipient of more than 5 antigens
not present in the donor, only I of 22 (or 4'5%) of the
recipient animals survived beyond 10 days, with or without
antirejection therapy.
Assessment of lesser donor and recipient differences in
leucocyte antigens were made by placing the 26 sera into
5 groups. Within each group the agglutination reaction
was merely recorded as present or absent. The following
regrouping of antigens were employed: division A, 1 - 15
(groups I, 11 and Ill); division B, 16 - 26 (groups IV and
V); division e, divisions A and B (groups I - V); division
D, any antisera (1 - 26); division E (no groups, no re-
actions). These divisions were applied to tests on both the
donors and the recipients. Where the donor possessed one
or more leucocyte antigens not present in the recipient,
the following survival rates were recorded.
In division A (1 - 15) average survival was 12 days.
In division B (16 - 26) average survival was 5 days.
In division C (I or more antigens not common to donor or
recipient in both division A and division B) average sur-
vival was 8 days.
In division D (1 or more antigens not common to donor and
recipient in entire tested groups) average survival was
8·9 days.
In division E (no antigens in donors) average survival was
7·2 days.
Similar correlations were made in regard to recipients
possessing one or more leucocyte antigens not present in
the donor. The following survival periods were noted in
the 5 divisions:
In division A (1 - 15) average survival was 9 days.
In division B (16 - 26) average survival was 8·5 days.
In division C (1 or more antigens not common to recipient
and donor in both division A and division B), average
survival was 7·3 days.
In division D (I or more antigens in the entire group tested)
average survival was 8·3 days.
In division E (no antigens not common to recipient and
donor) average survival was 10·2 days.
Thus, in terms of either the donor or the recipient, the
greater the number of leucocyte antigens not common to
both, the shorter the survival period. In addition, on the
basis of the differences in survival periods, it appears that
when no leucocyte antigens are detected in the donor it
may be of less significance than if the antigens are totally
absent in the recipient. When the donor possesses leuco-
cyte antigens not possessed by the recipient, it seems as if
those in division B are more harmful to survival, regard-
less of the treatment. No such differentiation was observed
in terms of the recipient.
This system of grouping the various antiserum factors
does, however, prevent the estimation of the relative im-
p:Jrtance of a single antiserum or of small groups of anti-
TABLE IJ. LEUCOCYTE TYPING RESULTS
Human antisera groups
PO days
No. Treatment 1-5 6-10 JI-15 16-21 22-26 survival
1 Control + + + + + 17
2 Control 0 0 0 0 0 6
3 Control + + + 0 0 15
4 Control 0 0 0 0 0 11
'" 5 Thalidomide + 0 0 0 0 12" 6 Thalidomide + 0 0 0 0 6<>::: 7 Chloroquine 0 0 + 0 0 15....
8 Chloroquine 5
~
+ + + + +
9 Chloroquine + 0 0 + + 8- 10 Imuran 0 0 0 0 0 7.§ 11 RNA-ase 0 0 0 0 0 9
.s. 12 RNA-ase 0 0 0 0 0 6
<> 13 RNA-ase 0 0 0 0 0 4".. 14 Goat y-globulin + 11~ + + + +.. 15 Kidney-cell fraction 0 0 0 0 0 7
c 16 Kidney-cell fraction 0 + + 0 + 6:::c 17 Kidney-cell fraction + 0 0 0 + 6
~ 18 Kidney-cell fraction 0 + 0 + + 7
19 Kidney-cell fraction 0 0 0 0 0 8
20 Kidney-cell fraction 0 0 0 + 0 5
21 Cortisone + 0 0 + 0 5
22 Cortisone 0 + 0 + 0 7
Average survival +9/22 (41 YJ + 7/22 (31·8 %) +6/22 (27'2%) +8/22 (36·4%) +7/22 (31,8%)
9·4 days 9·7 days 11·5 days 8·1 days 8·9 days 8·3 days
6
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sera among the 26 types tested. It also makes no allowance
for the total number of antigenic differences between
specific donor or recipient pairs, or vice versa, in terms of
leucocyte antigens.
Tables II and III further elucidate these differences.
Table II presents more detailed findings in leucocyte anti-
gen differences in terms of those possessed by the donor,
and not by the recipient. As shown in Table ll, a similar
frequency of antigens was detected in all the groups. The
difference varied from 27·2 to 41 %. The presence of leuco-
cyte antigens in antisera-groups 16 - 21 or 22 - 26 again
were associated with a shorter survival rate when com-
pared with antisera-groups 1 - 5, 6 - 10, or 11 - 15. This
suggested that, when the donor possessed leucocyte anti-
gens not present in the recipient (especially those in groups
16 - 26), decreased survival rates were noted irrespective
of the various forms of treatment employed.
Comparison of the distribution of leucocyte antigens,
seen in the recipient but not in the donor, are shown in
Table Ill. Within the various subgroups of antisera tested,
no particular benefit in terms of survival rate could be
appreciated when any specific antigen was absent. The
frequency of antigens of any subgroup present in the reci-
pient but not in the donor was again similar (41 - 54·5%).
There were, however, more leucocyte antigens present in
each group. Thus no particular antigen, as tested by a
particular antiserum, could be identified as being associated
with a poorer graft survival. However, as seen in Tables
II and Ill, in this particular series of animals, the recipients
more frequently possessed leucocyte antigens not seen in
the donor rather than conversely. Thus, in 20 of the 26
human antisera tested, the recipients possessed solitary leu-
cocyte antigens more frequently than the donors. In only
2 of the antisera tested (numbers 2 and 25) did the donor
more frequently possess a leucocyte antigen not seen in the
recipient. This difference between donor and recipient in
terms of leucocyte antigen specificity is a likely explana-
tion for the differences in survival periods noted when the
donor possessed antigens not also seen in the recipient. In
other words, the leucocyte antigens were more evenly
distributed in the recipients.
Exchange of Renal Grafts
In 5 instances grafts were simultaneously exchanged
between donor and recipient pairs, both with and without
antirejection treatment (Table I, cases 1 - 4, 10, 16 - 19, 21).
Thus the differences in leucocyte antigens between donor
and recipient were exchanged in every instance. From 2
to 10 leucocyte antigens were different between donor and
recipient. In 3 of the 5 pairs of renal allografts a shorter
survival was observed when the recipient possessed leuco-
cyte antigens not present in 'he donor, irrespective of
whether antirejection treatment was given or not. Of the
26 human antisera tested, significant blood leucocytes
(antigen serotypes) were: 1, 5, 7, 8, 9, 10, 11, 17, 18, 20,
21 and 25. It is interesting to note that of these 12 anti-
gens, as determined by the various tests, only one (21) was
commonly, or more frequently, observed in the 100 am-
mals tested (Figs. 1 and 2). When these antigens were
present in the recipient or donor, a shorter survival time
was noted.
It is at present unknown how similar or different these
various numbered human antisera are, both in terms of
antisera prepared by others, and in terms of their own
inherent differences."'" Antisera from transplanted animals
were also retested postoperatively for the possible presence
of antibodies against the donor. The results were variable.
In three instances no alterations were observed for as long
as 18 days after allotransplantation. Further studies on'
animals surviving for longer periods are in progress. A
larger number of transplantations are required before
definite conclusions can be reached on the basis of post-
operative serological alterations.
TABLE m. LEUCOCYTE TYPING-RESULTS
Human antisera groups
PO days
No. Treatment 1-5 6-10 11-15 16-21 22-26 survival
I Control 0 0 0 0 0 17
2 Control + + + + + 6
3 Control 0 0 0 iO' 0 15
4 Control + + + 0' 0 11
~ 5 Thalidomide + + + + 0 12
'" 6 Thalidomide + + 0 + 0 6:::
~ 7 Chloroquine + 0 + + 0 15
~ 8 Chloroquine + 0 + + 0 5
~. 9 Chloroquine + + + + 0 8
is 10 Tmuran + 0 0 + 0 7.g 11 RNA-ase 0 + 0 + 0 912 RNA-ase + + + + + 6
,:: 13 RNA-ase + 0 + + + 4
14 Goat y-globulin 0 0 0 0 + 11.:: 15 Kidney-ce1l fraction 0 0 0 0 0 7'".~ 16 Kidney-cell fraction + 0 0 0 + 6'-' 17 Kidney-cell fraction 0 + + 0 + 6'"~ 18 Kidney-cell fraction 0 0 0 0 0 7
19 Kidney-cell fraction 0 + 0 + + 8
20 Kidney-cell fraction 0 + + 0 + 5
21 Cortisone 0 0 0 0 0 5
22 Cortisone + + + + + 7
Average survival 12/22 (54'5%) 11/22 (50%) 11/22 (50%) 12/22 (51'5%) 9/22 (41 %)
7·8 days 7·6 days 7·7 days 7·8 days 6·6 days 8·4 days
31 May 1969 S.A. MEDICAL JOURNAL 693
Human and Baboon Leucocyte Antigens
Blood was obtained for testing from a baboon (P-l3)
who was compatible in terms of human ABO and MN
blood-groups with an anephric human awaiting renal allo-
transplantation. The leucocyte antigens tested in the man-
ner of Van Rood and associates' gave the results shown in
Table IV. The patient possessed 1 leucocyte antigenic
TABLE IV. COMPARISON OF HUMA ' A D BABOON LEUCOCYTE
ANTIGENS
Hwnan amisera rypes·
4a 4b 5a 5b 6a 6b 7a 7b 7e 7d 8a 9a
Patient +++ ++ ++ ++ ++ ++ ++ - +
Baboon P-13 + ++ + ++ ++ + + ++ - +
-After Van Rood et af/'
group (7c), not seen in the animal. Conversely the animal
possessed 2 known leucocyte antigens (7a and 7d) not
seen in the human. These results were interpreted as show-
ing a good tissue match.3 ,. Another baboon (Q-19) with
similar erythrocyte and leucocyte antigenic groups was
used in a modified third-man test.' Skin from the patient
and P-l3 were grafted onto Q-19 and an autograft of
Q-19 was performed as a control. All grafts were viable
for several days. No treatment was given. The animal was
killed on the 15th day after skin grafting. Serial blood
specimens obtained before and after grafting showed no
increase in total complement titre. No heterohaemolysins
or humoral antibodies were detected, while these can be
ob~erved within this time period in untreated baboon renal
allografts.· Histological examination of the human skin
graft showed a dense mononuclear infiltration with many
eosinophils underlying the dermis. A similar infiltrate, but
less marked, was seen underlying the dermis of the baboon
skin graft from P-l3, but no such reaction was observed
in the autograft. The observed infiltrate is similar to that
described in baboon renal allografts and human hetero-
grafts, and is associated with the rejection process." Thus,
although similarity may be observed between human and
baboon leucocytes, rejection will still occur without the-
rapy. Other animal species, in addition to man, have been
tested and found to possess similar leucocyte antigenic
groups.' In fact, common human erythrocyte antigens
have also been demonstrated in cell cultures of rhesus
monkey kidneys." These results notwithstanding, further
characterization of heterospecific antigens must be com-
pleted before grafts between man and other primates can
be safely attempted.
These findings confirm the previous observation that
skin grafts may be more difficult to match immunologic-
ally than kidney or tumour allografts.·
Organ-Specijicily Studies
The 20 preserved kidneys, stored for 24 hours with
constantly circulated perfusate, gave no reactions when
tested against the 26 human antiserum types. The perfu-
sate also gave no reaction when tested against the antisera.
These results indicate that the antigens present in baboon
leucocytes, as tested by the antisera, are not freely elutable
in the baboon kidney. As would be expected, similar
antigens, when present in the organs, are fixed to the tissue
and not attached in a more soluble fashion.'"
Homogenates of fresh baboon organs were tested, as in
the manner recently described in human studies: The
material reacted only with the 4a antiserum of Van Rood'
as judged by absorption studies. Similar studies performed
with the baboon leucocytes against the battery of 26
human antisera'" produced weak-positive reactions with
antisera 11, 16 and 25. Freeze-dried preparations were
made of the organs of the animal after death:" When these
were tested against the battery of human antisera in the
same manner as the leucocytes3 ,. the renal tissue from the
same animal was found to react against the same antisera
(numbers 11, 16 and 25).
This baboon renal tissue reacts against the battery of
human antisera in a manner similar to baboon leucocytes-.
Multiple tests with other organs prepared in a similar
fashion are in progress. The present results, however, sug-
gest that tissue typing of baboon organs, such as the
kidney, may be feasible with the presently available human
antisera.
DISCUSSION
The present report describes the frequency of occurrence
of baboon leucocyte antigens as tested with 26 human
leucocyte antisera and the alterations in survival rate of
baboon renal allografts matched for compatibility in terms
of human ABO erythrocyte groups, but differing in various
leucocyte antigens. These antigens were detected in baboon
leucocytes tested against a battery of 26 human antisera
prepared from pregnant human donors:" The results have
been interpreted to show that, regardless of the absence or
presence of antirejection treatment, the greater the number
of differences in leucocyte groups between donor and reci-
p:ent, the shorter the survival periods. This observation
further assists in current experimental attempts to charac-
terize the significant determinants of renal antigenicity in
the Chacma baboon.
These results also adequately demonstrate that certain
erythrocyte and leucocyte antigens are shared by both
baboon and man (Tables I - IV). This similarity has pro-
vided us with a non-human renal transplant model whose
reactions are applicable to current clinical transplant
problems.'"
The frequency distribution of the various leucocyte anti-
gens has been determined on 100 baboons, and will be
helpful in further histocompatibility testing in this and
other projects.
There are 3 or 4 major groups of antigens as tested with
the 26 antisera. This population distribution, observed in
a large number of animals, is similar in some respects to
human population studies:" However, the present antisera
have yet to be further characterized in terms of those
isolated by other investigators."'"
A marked difference in the distribution of different leu-
cocyte antigens was noted in more recipients than donors
in this experimental group (Tables 11 and UD.
When renal grafts were simultaneously exchanged be-
tween donor and recipient, 12 of the 26 human leucocyte
types tested appeared to have a deleterious effect on graft
survival period.
Skin tests between human and baboon kidney donors
(Table IV) have confirmed that, although good erythrocyte
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and leucocyte matching can be achieved, histological evi-
dence of rejection is still observed. Further studies on pri-
mate xenografts are currently in progress and may further
characterize the important antigenic differences.
In the present studies attempts were also made to relate
the observed leucocyte agglutinating antigens to other
antigens in the kidney and other organs. The studies indi-
cate that organ specific antigens fixed to renal tissue can-
not be eluted. On the other hand, the results obtained with
organ homogenates in humans,' and in the present studies,
indicate that the leucocyte agglutinating antigen testing is
in part relatable to other organ antigenic responses. Thus,
this method of leucocyte agglutination is a true test of
tissue compatibility. Further refinement in antigen-anti-
serum responses will therefore greatly assist organ trans-
plantation.
SUMMARY
Renal allografts were exchanged between adult male and fe-
male baboons, both with and without antirejection treatment.
In 5 pairs of animals renal grafts were simultaneously ex-
changed between donor and recipient. A total of 22 renal aIlo-
grafts were completed and matched in terms of their major
human ABO erythrocyte blood-groups. AIl were dead within
3 weeks after aIlotransplantation.
Before transplantation, the animals were tested for the pre-
sence of leucocyte antigens against a battery of 26 human anti-
serum types.
Differences between donor and recipient leucocyte antigens
were identified and related to the observed graft survival
periods. Twelve of the 26 leucocyte antigenic types least
commonly found in baboons, were more frequently associated
with shortened graft survival.
The oreater the number of differences in leucocyte antigens
betwee; donor and recipients, the shorter the graft survival,
irrespective of whether immunosuppressive treatment was em-
ployed or not.
Further tests in over 100 baboons have confirmed that this
species shares leucocyte antigens with humans. The frequency
distribution of these results is described. There are 3 or 4
commonly-occurring leucocyte antigen reactions as observed
with the battery of 26 human antisera tested.
Skin grafts, as part of a modified third-man test between an
anephric human and two baboons, all well matched in terms
of erythrocyte and leucocyte antigens, were performed. Sero-
logical and histological tests demonstrated the similarity in the
rejection process between man and baboon.
Organ perfusion studies of preserved kidneys demonstrated
that renal antigens, similar to those detected in baboon leuco-
cytes, are not elutable. Homogenates of baboon kidney reacted
with similar antisera as the leucocytes and thus demonstrated
that the antigens as tested are similar. Leucocyte antigenic
responses may thus be true tissue-typing criteria.
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DERMATOMYOSITIS IN THE TRANSVAAL AND ITS OCCURRENCE IN THE BANTU*
G. H. FlNDLAY AND D. A. WHITING, Section of Dermatology, AND T. W. SIMSON, Department of Pathology, University
of Pretoria
It has long been felt that dermatomyositis is an unduly
common disorder among the Bantu of the Transvaal.
Observant practitioners in the country districts are aware
of its occurrence without always being able to give a
name to the condition. At the Jane Furse Hospital,
Sekhukhuniland, Transvaal, the disorder is well known; 10
cases were seen between February 1958 and June 1963, 4
of which were reported in detail by- Horsfal1.' Since that
time a further 5 cases have been seen there, bringing the
total to 15 Bantu cases in 10 years. As this hospital serves
a population of 200,000 Bantu, the minimum annw.l inci-
den..:e of dermatomyositis in this racial group lies in the
region of 7·5 cases per million.
Over a 7-year period, 35 Bantu and 4 White cases of
dermatomyositis were seen by us at the H. F. Verwoerd
Hospital, Pretoria-an average of 5 Bantu cases per year.
By comparison, in the same hospital, the incidence of acute
lupus erythematosus in the Bantu has been found to be
2·4 cases per year.' The effective size of the Bantu com-
munity served by the hospital has never been estimated,
but it probably lies between 600,000 and I million inhabi-
tants. It can be seen that this figure for Pretoria gives a
frequency of dermatomyositis comparable with that found
in Sekhukhuniland. Supposing the hospital at Pretoria
'Date received: 22 August 1968.
served the entire Northern Transvaal Bantu (2t million),
the annual incidence of dermatomyositis would be not less
than 2·1 cases/million.
This minimum figure contrasts sharply with a figure for
polymyositis (of which some 50% are examples of
dermatomyositis) of 1·2 cases/ million/ year in Southern
California and Northern England.' In these two White
communities, the figure for polymyositis is therefore about
one-fifth of our frequency estimate in the Bantu for
dermatomyositis alone, making the discrepancy greater still.
Even if we ignore the patients who failed to come to hos-
pital and misdiagnoses in those who did, the Bantu
incidence figures for dermatomyositis are still 10 times
higher than in the White.
Comparing 3 serious 'collagenoses', systemic scleroderma,
systemic lupus erythematosus and dermatomyositis, one's
impressions of relative frequency in Pretoria among Bantu
and Whites are as set out in Table J. Rough annual ad-
TABLE 1. RELATIVE FREQUE 'CY OF LE, SCLERODERMA A 'D
DERMATOMYOSmS
Frequency
Race Commonest Intermediate Rare ratio
White Acute LE Scleroderma Dermato- (7 : 2'5 : I?)
myositis
Bantu Derm.to- Acute LE Scleroderma (5'5 : 2'4 : O?)
myositis
